Sign in
New Treatment Paradigm for Infectious Endophthalmitis: Results from the Mexican Endophthalmitis Study Group Protocol 1 and 3
Raul Velez-Montoya, MD
Updates from the Field
2024
Two-Year Results From the Subretinal RGX-314 Gene Therapy Phase 1/2a Study for the Treatment of Neovascular AMD
Robert L. Avery, MD
2021
Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study
W. Lloyd Clark, MD, FASRS
2022
Category: wet AMD